FDA Sued Over Delay On Pfizer Alzheimer's Drug Decision

Law360, New York (September 5, 2012, 3:36 PM EDT) -- A consumer advocacy group sued the U.S. Food and Drug Administration Wednesday in Washington federal court, in a bid to force the agency to decide on its petition to pull a Pfizer Inc. Alzheimer's drug from the market over efficacy and safety concerns.

Public Citizen Inc. filed a petition with the FDA in May 2011 that contended a 23-milligram dose of Aricept, manufactured by Eisai Co. Ltd. and marketed by Pfizer, failed to meet agency-required efficacy criteria for dementia drugs. The dose also demonstrated significantly more...
To view the full article, register now.